Zinc Chloride
Electrolyte Solutions
Sold as Zincum Muriaticum
- Drug class
- Electrolyte Solutions
- Availability
- Over-the-counter
- Routes
- Oral
- Markets covered
- 1
- Products on record
- 1
- FDA reports (12 mo)
- 1,970
Overview
Zinc Chloride is an active pharmaceutical ingredient in the Electrolyte Solutions group (B05XA). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| US United States | FDA | 1 | October 4, 2023 |
USUnited States· FDA
1 product
1 product on record with this regulator. Detailed label text (uses, dosage, side effects) is being ingested — the original document is linked under Sources [1].
Most-reported reactions to the US regulator (12 mo to June 4, 2026): 1,970 reports total. [2]
- Fatigue 201
- Off Label Use 168
- Nausea 164
- Headache 155
- Dyspnoea 151
- Diarrhoea 150
- Drug Ineffective 126
- Pain 119
- Dizziness 117
- Asthenia 111
- Rash 109
- Product Dose Omission Issue
Drug interactions
Known interactions involving Zinc Chloride. Select one for details. This list is informational and not a complete interaction checker.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]FDA DailyMed · 06ecda16-b4b2-1b… · revised October 4, 2023 [PDF]
- [2]OpenFDA adverse-event reports (US), 12 months ending June 4, 2026.
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.